highly significantp < 0.001
The Group 2 (omeprazole treated) post‐ride gastric scores (0.88 ± 0.15) and prevalence (0.73 ± 0.08) did not differ significantly from the pre‐ride gastric scores and prevalence of both Group 1 and Group 2 while the difference was highly significant (p < 0.001) when compared to non‐treated horses post‐ride gastric scores (0.88 ± 0.15 vs 1.60 ± 1.15) and prevalence (0.73 ± 0.08 vs 0.93 ± 0.05).